TipRanks
Go Ultimate55% OFF

Medicskin Holdings Ltd. (8307) AI Stock Analysis

HK:8307

Medicskin Holdings Ltd.

(HKEX:8307)

Select Model
Rating:46Neutral
Price Target:HKD 0.15â–¼(-1.32% Downside)
Action:reiterated
Date:09/30/26

The score is held back primarily by elevated leverage and weakening revenue/margin trends despite a return to small profitability and consistently positive free cash flow. Technically, the stock shows near-term strength above key moving averages, but overbought signals raise pullback risk. Valuation provides limited support given the high P/E and no dividend yield data.

Positive Factors
Consistent Cash GenerationConsistently positive operating and free cash flow gives the company an internal funding source for ongoing operations and reduces reliance on external financing. Although FY2026 free cash flow weakened, continued cash generation provides a durable liquidity base over the next several quarters.
Negative Factors
Elevated LeverageLeverage remains materially above the company’s earlier levels, while equity is small relative to the asset base. This reduces financial flexibility, increases sensitivity to weaker operating performance, and may constrain investment or cash allocation over the next several quarters.

Medicskin Holdings Ltd. (8307) vs. iShares MSCI Hong Kong ETF (EWH)

-50%-40%-30%-20%-10%0%10%20%HK:8307-23.62%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 60.30M
Dividend Yield
―
Average Volume (3M)
245.76K
Price to Earnings (P/E)
64.3
Beta (1Y)
0.24
Revenue Growth
6.13%
EPS Growth
―
Country
Hong Kong
Employees
27
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Medicskin Holdings Ltd. Business Overview & Revenue Model

Company Description

Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, su...

Medicskin Holdings Ltd. Financial Statement Overview

Summary

Financial profile is mixed: revenue has weakened recently (FY2026 down ~16%) and margins deteriorated (gross margin fell sharply to ~37%), while leverage is elevated (debt-to-equity ~3.4x). Offsetting this, cash generation has remained positive (positive operating cash flow and free cash flow each year) and the company returned to a small profit in FY2026.

Income Statement

46Neutral

Balance Sheet

32Negative

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue45.55M47.87M45.11M49.13M45.54M49.15M
Gross Profit23.33M17.53M22.87M15.33M36.68M42.14M
EBITDA9.85M7.48M6.29M6.78M6.40M14.55M
Net Income-1.31M936.00K-3.38M-3.05M-3.54M3.92M
Balance Sheet
Total Assets51.07M51.07M57.44M40.06M46.37M56.67M
Cash, Cash Equivalents and Short-Term Investments16.73M29.46M17.34M6.93M6.37M15.47M
Total Debt17.57M17.57M22.79M5.76M11.93M18.67M
Total Liabilities45.84M45.84M53.25M32.48M35.21M42.49M
Stockholders Equity5.23M5.23M4.20M10.95M14.47M17.43M
Cash Flow
Free Cash Flow7.84M4.54M8.29M9.12M946.00K2.33M
Operating Cash Flow10.10M5.81M9.13M10.52M3.25M4.29M
Investing Cash Flow-5.72M-7.63M-191.00K-1.40M-5.67M-1.82M
Financing Cash Flow-9.17M-5.22M1.48M-7.21M-6.74M-17.94M

Medicskin Holdings Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price0.15

Price Trends

50DMA0.13Positive
100DMA0.13Positive
200DMA0.14Positive

Market Momentum

MACD0.00Negative
RSI60.34Neutral
STOCH80.77Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8307, the sentiment is Positive. The current price of 0.15 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.13, and above the 200-day MA of 0.14, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 60.34 is Neutral, neither overbought nor oversold. The STOCH value of 80.77 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8307.

Medicskin Holdings Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HK:8307 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:2373HK:237379OutperformHKD 4.17B8.8131.63%4.33%22.71%43.58%
HK:1846HK:184663NeutralHKD 703.50M285.710.20%2.00%20.54%-96.74%
HK:2135HK:213555NeutralHKD 62.39M3.9412.17%―36.68%―
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:6639HK:663948NeutralHKD 1.03B31.061.27%―――
HK:8307HK:830746NeutralHKD 60.30M64.2819.79%―6.13%―

* Healthcare Sector Average

Performance Comparison

-50%-25%0%25%50%HK:8307HK:1846HK:2135HK:2373HK:6639HK:2508Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:8307 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:8307Medicskin Holdings Ltd.0.15-0.03-15.56%
HK:1846EuroEyes International Eye Clinic Limited2.20-1.09-33.17%
HK:2135Raily Aesthetic Medicine International Holdings Limited0.11-0.00-3.45%
HK:2373Beauty Farm Medical & Health Industry, Inc.16.62-12.33-42.60%
HK:6639Arrail Group Ltd.1.83-0.09-4.74%
HK:2508Saint Bella Inc.2.30-3.70-61.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 30, 2026